ALTUVOCT 4 000 IU, powder and solvent for solution for injection bottle, 3 ml
Active ingredients: ÉFANÉSOCTOCOG ALFA
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 3 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALTUVOCT 4 000 UI, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre de 4 000 UI + 1 seringue préremplie en verre de 3 mL + 1 tige de piston + 1 adaptateur pour flacon + 1 set de perfusion
- Marketing authorisation holder
- SWEDISH ORPHAN BIOVITRUM (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60495577CIP73029730CIP133400930297308Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉFANÉSOCTOCOG ALFApoudre | 4000 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.